Home - Invivoscribe

Cat #: 40880008

This DNA control is adjusted to a final concentration of 15 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient b...

View Product

Cat #: 40920020

TCRG Negative Control DNA

This DNA control is adjusted to a final concentration of 50 µg/mL in 1/10 TE (1mM Tris-HCl (pH 8.0), 0.1 mM EDTA). This diluent provides sufficient b...

View Product

Cat #: 40880420

1% IVS-0007 Clonal Control DNA

The IVS-0007 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: IGH, IGK, IGL Translocations: BCL2/JH t(14;18) Mbr Mutati...

View Product

Cat #: 40880480

1% IVS-0008 Clonal Control DNA

The IVS-0008 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: IGH1, TRB, TRG Translocations: n/c Mutations: n/c 1 This...

View Product

Cat #: 40880540

1% IVS-0009 Clonal Control DNA

The IVS-0009 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: TRB, TRG Translocations: n/c Mutations: n/c ...

View Product

Cat #: 40881140

1% IVS-0019 Clonal Control DNA

The IVS-0019 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: IGH, IGK Translocations: n/c Mutations: n/c ...

View Product

Cat #: 40881260

1% IVS-0021 Clonal Control DNA

The IVS-0021 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: TRB, TRD, TRG Translocations: n/c Mutations: n/c ...

View Product

Cat #: 40881800

1% IVS-0030 Clonal Control DNA

The IVS-0030 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: IGH, IGK Translocations: IGH-BCL2 t(14;18) Mutations: n/...

View Product

Cat #: 40881860

1% IVS-0031 Clonal Control DNA

The IVS-0031 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: IGH, IGK Translocations: IGH–BCL2 t(14;18) mcr Muta...

View Product

Cat #: 40880220

10% IVS-0004 Clonal Control DNA

The IVS-0004 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: TRB, TRG Translocations: n/c Mutations: n/c ...

View Product

Cat #: 40880400

10% IVS-0007 Clonal Control DNA

The IVS-0007 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: IGH, IGK, IGL Translocations: IGH-BCL2 t(14;18)Mbr Mutati...

View Product

Cat #: 40880520

10% IVS-0009 Clonal Control DNA

The IVS-0009 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: TRB, TRG Translocations: n/c Mutations: n/c ...

View Product

Cat #: 40880580

10% IVS-0010 Clonal Control DNA

The IVS-0010 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: IGH, IGK, IGL Translocations: IGH–BCL1 t(11;14) Mut...

View Product

Cat #: 40881120

10% IVS-0019 Clonal Control DNA

The IVS-0019 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: IGH, IGK Translocations: n/c Mutations: n/c ...

View Product

Cat #: 40881240

10% IVS-0021 Clonal Control DNA

The IVS-0021 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: TRB, TRD, TRG Translocations: n/c Mutations: n/c ...

View Product

Cat #: 40881780

10% IVS-0030 Clonal Control DNA

The IVS-0030 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: IGH, IGK Translocations: IGH–BCL2 t(14;18) Mutation...

View Product

Cat #: 40881840

10% IVS-0031 Clonal Control DNA

The IVS-0031 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: IGH, IGK Translocations: IGH–BCL2 t(14;18) mcr Muta...

View Product

Cat #: 40880210

20% IVS-0004 Clonal Control DNA

The IVS-0004 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: TRB, TRG Translocations: n/c Mutations: n/c ...

View Product

Cat #: 40880390

20% IVS-0007 Clonal Control DNA

The IVS-0007 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: IGH, IGK, IGL Translocations: IGH–BCL2 t(14;18)Mbr ...

View Product

Cat #: 40880510

20% IVS-0009 Clonal Control DNA

The IVS-0009 Clonal Control DNA can be used as a positive control for: Gene Rearrangements: TRB, TRG Translocations: n/c Mutations: n/c ...

View Product

Invivoscribe provides a full range of standardized CE-marked in vitro diagnostic cGMP products for hematology-oncology, as well as RUO assays, analyte specific reagents (ASRs), and DNA & RNA controls.

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

October 30th, 2020
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

All Products

Coming Soon

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Coming Soon

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Invivoscribe provides a full range of standardized CE-marked in vitro diagnostic cGMP products for hematology-oncology, as well as RUO assays, analyte specific reagents (ASRs), and DNA & RNA controls.

The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

November 17th, 2020 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

October 30th, 2020 Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

All Products

Coming Soon

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

Coming Soon

Our New Document Search Feature

Need Help Placing an Online Order?

Contact our Customer Service Team

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

November 17th, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

October 30th, 2020
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma